(Q33490745)

27 July 2017

title

Phase I/II study of cisplatin, 5-fluorouracil and alpha-interferon for recurrent carcinoma of the head and neck (English)

1 reference

27 July 2017

1 reference

head and neck carcinoma

1 reference

3

Lippman SM

1 reference

27 July 2017

Huber MH

1

1 reference

27 July 2017

Shirinian M

2

1 reference

27 July 2017

Dimery IW

4

1 reference

27 July 2017

Frankenthaler RA

5

1 reference

27 July 2017

Hong WK

6

1 reference

27 July 2017

publication date

1 January 1994

1 reference

Investigational New Drugs

27 July 2017

published in

1 reference

27 July 2017

volume

12

1 reference

27 July 2017

issue

3

1 reference

27 July 2017

page(s)

223-229

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00873963

27 July 2017

exact match

0 references

cites work

Antineoplastic activity of the combination of interferon and cytotoxic agents against experimental and human malignancies: a review

1 reference

12 December 2020

Favorable long-term survival following induction chemotherapy with cisplatin, fluorouracil, and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancer

1 reference

12 December 2020

Cisplatin, fluorouracil, and leucovorin augmented by interferon alfa-2b in head and neck cancer: a clinical and pharmacologic analysis

1 reference

12 December 2020

Comprehensive criteria for assessing therapy-induced toxicity

1 reference

12 December 2020

Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study

1 reference

12 December 2020

A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck

1 reference

12 December 2020

Phase II trial of 13-cis-retinoic acid plus interferon-α in recurrent head and neck cancer

1 reference

12 December 2020

Treatment of nasopharyngeal carcinoma with human leukocyte interferon

1 reference

12 December 2020

Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer

1 reference

12 December 2020

Interferon effects upon the adenocarcinoma 38 and HL-60 cell lines: antiproliferative responses and synergistic interactions with halogenated pyrimidine antimetabolites

1 reference

12 December 2020

Fluorouracil and recombinant alfa-2a-interferon: an active regimen against advanced colorectal carcinoma

1 reference

12 December 2020

A randomized trial of cisplatin (CACP) + 5-fluorouracil (5-FU) infusion and CACP + 5-FU bolus for recurrent and advanced squamous cell carcinoma of the head and neck

1 reference

12 December 2020

Cisplatin, 5-fluorouracil, and high-dose oral leucovorin for advanced head and neck cancer

1 reference

12 December 2020

Prospective randomized trial of high-dose cisplatin and fluorouracil infusion with or without sodium diethyldithiocarbamate in recurrent and/or metastatic squamous cell carcinoma of the head and neck

1 reference

12 December 2020

1 reference

12 December 2020

Preliminary trial of nonrecombinant interferon alpha in recurrent squamous cell carcinoma of the head and neck

1 reference

12 December 2020

Continuous infusion high-dose leucovorin with 5-fluorouracil and cisplatin for untreated stage IV carcinoma of the head and neck

1 reference

12 December 2020

Combined effects of 5-fluorouracil and interferon on proliferation of human neoplastic cells in culture

1 reference

12 December 2020

A pilot study of interferon alfa-2a in combination with fluorouracil plus high-dose leucovorin in metastatic gastrointestinal carcinoma

1 reference

12 December 2020

Augmentation of cytotoxicity of chemotherapy by human alpha-interferons in human non-small cell lung cancer xenografts

1 reference

12 December 2020

Larynx preservation with combined chemotherapy and radiation therapy in advanced but resectable head and neck cancer.

1 reference

12 December 2020

Phase II study of fluorouracil and recombinant interferon alfa-2a in previously untreated advanced colorectal carcinoma

1 reference

12 December 2020

Phase I trial of 5-fluorouracil and recombinant alpha 2a-interferon in patients with advanced colorectal carcinoma

1 reference

12 December 2020

Decreased catabolism of fluorouracil in peripheral blood mononuclear cells during combination therapy with fluorouracil, leucovorin, and interferon alpha-2a

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00873963

1 reference

Dimensions Publication ID

27 July 2017

1026704826

0 references

1 reference